Lincolnshire, IL, United States of America

Basma M Ibrahim

USPTO Granted Patents = 3 


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2021

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Basma M Ibrahim

Introduction

Basma M Ibrahim is a notable inventor based in Lincolnshire, IL (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of liquid formulations of levothyroxine. With a total of three patents to her name, her work has the potential to impact the treatment of thyroid conditions.

Latest Patents

Basma's latest patents focus on the formulation of levothyroxine liquid products. The first patent describes a pharmaceutical product that includes a liquid formulation comprising levothyroxine or a pharmaceutically acceptable salt thereof. This formulation includes tromethamine, sodium iodide, and water, with a pH ranging from about 9.0 to about 11.5. The invention emphasizes the stability and readiness for use of the liquid formulation. The second patent mirrors the first, reinforcing the innovative approach to creating stable and effective liquid formulations of levothyroxine.

Career Highlights

Basma M Ibrahim is currently employed at Fresenius Kabi USA, LLC, where she continues to advance her research and development efforts in pharmaceuticals. Her work is characterized by a commitment to improving patient care through innovative drug formulations.

Collaborations

Basma collaborates with her coworker, Arunya Usayapant, who is also involved in the pharmaceutical field. Their partnership exemplifies the collaborative spirit that drives innovation in research and development.

Conclusion

Basma M Ibrahim's contributions to the field of pharmaceuticals, particularly through her patents on levothyroxine liquid formulations, highlight her role as an influential inventor. Her work not only showcases her expertise but also has the potential to enhance treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…